Basic information
- CAS
57-08-9- Standard SMILES
CC(=O)NCCCCCC(=O)O- InChIKey
WDSCBUNMANHPFH-UHFFFAOYSA-N- Molecular formula
- C8H15NO3
- Average molar mass
- 173.21 g/mol
- Monoisotopic mass
- 173.10519334
Names & identifiers
- Preferred name
- 6-Acetylaminocaproic acid
- IUPAC
- 6-acetamidohexanoic acid
- English name
- 6-Acetamidohexanoic acid
- Molecular formula
- C8H15NO3
- Molecular weight
- 173.21
Names & synonyms
Show more names
Database identifiers
- CAS
57-08-9- PubChem CID
- 2005
- DTXSID
DTXSID1045879- ChEMBL
CHEMBL2105922- ChEBI
CHEBI:134808- UNII
- 7IC4BO7D3R
- EC Number
- 200-310-8
- Nikkaji
- J4.575F
Properties
Computed structural properties
- XLogP
- 0.1
- Topological polar surface area
- 66.4 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 3
- Rotatable bonds
- 6
- Heavy atoms
- 12
- Formal charge
- 0
- Complexity
- 156
Experimental & physicochemical properties
Physicochemical properties
- Melting point
- 102 · 102-104 °C(lit.)
- Boiling point
- 303.86 °C · 303.86°C (rough estimate)
- Density
- 1.1599 · 1.1599 (rough estimate)
- refractive index
- 1.459 · 1.4590 (estimate)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- DMSO (Sparingly), Methanol (Slightly)
- pka
- 4.75 · 4.75±0.10(Predicted)
- form
- Solid
- color
- White to Off-White
- Merck
- 14 · 14,45
- Cosmetics Ingredients Functions
- ANTIOXIDANT
- InChI
- InChI=1S/C8H15NO3/c1-7(10)9-6-4-2-3-5-8(11)12/h2-6H2,1H3,(H,9,10)(H,11,12)
- InChIKey
- WDSCBUNMANHPFH-UHFFFAOYSA-N
- SMILES
- C(O)(=O)CCCCCNC(C)=O
- LogP
- -0.5 · -0.500 (est)
- CAS DataBase Reference
- 57 · 57-08-9(CAS DataBase Reference)
- FDA UNII
- 7 IC4BO7D3R · 7IC4BO7D3R
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 317 · H317-H319
- Precautionary statements
- 280 · P280-P305+P351+P338
- Safety Statements
- 24 · 24/25
- WGK Germany
- 3 · 3
- HS Code
- 29241900 · 29241900
- REACH Registrations
- Active
Safety & regulation
GHS classification
GHS Classification
This chemical does not meet GHS hazard criteria for 50% (2 of 4) of reports.
Danger
H315 (50%): Causes skin irritation [Warning Skin corrosion/irritation];H318 (50%): Causes serious eye damage [Danger Serious eye damage/eye irritation];H335 (50%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 4 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 2 of 4 reports by companies.;There are 2 notifications provided by 2 of 4 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Hazard information
Regulatory Information
Chemical: Hexanoic acid, 6-(acetylamino)-
Status: Active Update: 07-02-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/30101
Regulatory information
Regulatory Information
Chemical: Hexanoic acid, 6-(acetylamino)-
Status: Active Update: 07-02-2022 https://echa.europa.eu/registration-dossier/-/registered-dossier/30101
Safety data
- wgk
- 3
- hs_code
- 29241900
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- safety_code
- 24/25
- Hazard statements
- H317-H319
- REACH Registrations
- Active
- Precautionary statements
- P280-P305+P351+P338
Chemistry & industry
Pharmacology
MeSH Pharmacological Classification
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.
Applications
Useswound healing agent
Uses6-Acetamidohexanoic acid is used after oral administration of an antiulcer agent, zinc acexamate (ZAC) for treatment of gastric ulcer or small bowel inflammation.
Upstream & downstream products
Upstream raw materials
Downstream products
Suppliers90 total
Additional notes
DefinitionChEBI: Acexamic acid is a medium-chain fatty acid.
Related reactions
Compound notes
Loading…